ESC 365 - Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors

Delegates Premium Access

Validation of the LIFE-CVD2 model for lifetime cardiovascular risk prediction in cancer survivors

Session: Risk prediction: novel markers

Topic: Scores

Speaker: Mrs M. Gynnild (Trondheim, NO)

Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

About the speaker

Mrs Mari Nordboe Gynnild

St. Olav University Hospital, Trondheim (Norway)

0 follower

4 more presentations in this session

The prognostic value of peak postoperative high-sensitive troponin T in patients undergoing elective cardiac surgery and rehabilitation

Speaker: Doctor F. Robotti (Milan, IT)

The use of ophthalmic fundus imaging to predict cardiovascular risk factors: a systematic review

Speaker: Doctor A. Abo Dan (Quebec, CA)

Prevalence and predictors of elevated cardiovascular risk in patients with subclinical hypothyroidism

Speaker: Doctor A. Albulushi (Muscat, OM)

Time to change the electrocardiography (ECG) indices of left ventricular hypertrophy: the Bialystok PLUS and SHIP-TREND population-based studies

Speaker: Doctor M. Chlabicz (Bialystok, PL)

Access the full session

Risk prediction: novel markers

Speakers: Mrs M. Gynnild, Doctor F. Robotti, Doctor A. Abo Dan, Doctor A. Albulushi, Doctor M. Chlabicz

About the event

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources